Ann Indian Acad Neurol. 2014 Oct;17(4):398-404. doi: 10.4103/0972-2327.144008.
Low plasma antioxidant status in patients with epilepsy and the role of antiepileptic drugs on oxidative stress.
Annals of Indian Academy of Neurology
Bindu Menon, Krishnan Ramalingam, Rajendiran Vinoth Kumar
Affiliations
Affiliations
- Department of Neurology, Narayana Medical College and Superspeciality Hospital, Chintareddypalem, Nellore, Andhra Pradesh, India.
- Department of Biochemistry, Narayana Medical College and Superspeciality Hospital, Chintareddypalem, Nellore, Andhra Pradesh, India.
PMID: 25506160
PMCID: PMC4251012 DOI: 10.4103/0972-2327.144008
Abstract
BACKGROUND: Oxidative stress has been implicated in various disorders including epilepsy. We studied the antioxidant status in patients with epilepsy and aimed at determining whether there was any difference in the antioxidant levels between patients and controls, patients who are not on antiepileptic drugs (AEDs), and on treatment, between individual AEDs and patients on monotherapy and polytherapy.
MATERIALS AND METHODS: Antioxidant levels like catalase, glutathione peroxidase (GPx), vitamin E, glutathione (GSH), thiol group (SH), uric acid, and total antioxidant capacity (TAC) were compared between 100 patients with epilepsy and equal number of controls. Twenty-five patients who were not on AEDs were compared with patients on AEDs and the control group. Patients were divided into monotherapy and polytherapy group and antioxidant status was compared between the two groups and between individual drugs.
RESULTS: Catalase, SH, vitamin E, and TAC were significantly low in patients with epilepsy than those in the control group (P < 0.001). GSH and uric acid did not show any difference; GPx in patients was significantly higher than those in the control group There were no differences in the antioxidant levels between the treated and the untreated groups; however, it was lower in untreated patients than controls (P < 0.001), suggesting that AEDs do not modify the oxidative stress. Patients on Valproate (VPA) showed higher catalase and GPx levels. Catalase was higher in the monotherapy than polytherapy group (P < 0.04).
CONCLUSION: Our study found significantly low levels of antioxidant in patients as compared to controls. AED did not influence the antioxidant status suggesting that seizures induce oxidative stress.
Keywords: Antiepileptic drugs; catalase; epilepsy; glutathione; glutathione peroxidase; seizures; thiol goup; total antioxidant capacity; uric acid; vitamin E
References
- Epilepsy Behav. 2011 Dec;22(4):678-84 - PubMed
- Free Radic Biol Med. 1993 Jun;14(6):615-31 - PubMed
- J Lab Clin Med. 1963 May;61:882-8 - PubMed
- Pediatr Pharmacol (New York). 1980;1(2):129-34 - PubMed
- Farmaco. 1995 Nov;50(11):811-3 - PubMed
- Acta Med Okayama. 2004 Jun;58(3):111-8 - PubMed
- Brain Res. 2012 Apr 27;1451:19-26 - PubMed
- Brain. 2008 Aug;131(Pt 8):2061-70 - PubMed
- Yonsei Med J. 1993 Mar;34(1):1-10 - PubMed
- Life Sci. 2006 Mar 13;78(16):1884-91 - PubMed
- Clin Exp Nephrol. 2005 Sep;9(3):195-205 - PubMed
- Neurochem Res. 2004 Sep;29(9):1749-53 - PubMed
- Epilepsia. 2007 Jul;48(7):1388-95 - PubMed
- Am J Med Genet. 1995 Jun 5;57(2):225-8 - PubMed
- Brain Res Bull. 2007 Jan 9;71(4):372-5 - PubMed
- Science. 1973 Feb 9;179(4073):588-90 - PubMed
- Epilepsy Res. 2004 Nov;62(1):65-74 - PubMed
- Curr Top Med Chem. 2012;12(9):994-1007 - PubMed
- Epilepsia. 2009 May;50 Suppl 5:11-4 - PubMed
- Biol Trace Elem Res. 2013 May;152(2):180-6 - PubMed
- Curr Pharm Des. 2005;11(32):4145-51 - PubMed
- Nucleosides Nucleotides Nucleic Acids. 2008 Jun;27(6):608-19 - PubMed
- Neurosci Lett. 2007 Jun 8;420(1):76-9 - PubMed
- Methods Enzymol. 1984;105:121-6 - PubMed
- Proc Natl Acad Sci U S A. 1990 Jul;87(13):5144-7 - PubMed
- Epilepsia. 2001 Jun;42(6):796-803 - PubMed
- Clin Chem. 1978 Apr;24(4):585-90 - PubMed
- Epilepsy Res. 2001 Aug;46(2):121-8 - PubMed
- Arterioscler Thromb Vasc Biol. 2000 Mar;20(3):698-702 - PubMed
- Pol J Pharmacol. 2002 Sep-Oct;54(5):521-4 - PubMed
- Acta Physiol Scand Suppl. 1980;492:153-68 - PubMed
- Analyst. 1972 Feb;97(151):142-5 - PubMed
- Life Sci. 1997;61(4):437-43 - PubMed
- Epilepsy Res. 2008 Feb;78(2-3):171-7 - PubMed
- Toxicology. 2006 Jan 16;217(2-3):228-32 - PubMed
- J Basic Clin Physiol Pharmacol. 2000;11(1):73-81 - PubMed
- Brain Res. 1999 Nov 20;847(2):347-51 - PubMed
- Epilepsy Behav. 2009 Jan;14 Suppl 1:16-25 - PubMed
- Arterioscler Thromb Vasc Biol. 2002 Jul 1;22(7):1162-7 - PubMed
- Arch Biochem Biophys. 1959 May;82(1):70-7 - PubMed
- Epilepsy Res. 2002 Jan;48(1-2):71-5 - PubMed
- Epilepsy Res. 2007 May;74(2-3):183-92 - PubMed
- Clin Chim Acta. 2001 Jan;303(1-2):19-24 - PubMed
- Lancet Neurol. 2002 Jul;1(3):173-81 - PubMed
- Epilepsia. 2005;46 Suppl 7:45-51 - PubMed
- Science. 1959 Nov 13;130(3385):1319-23 - PubMed
- Eur Neurol. 2007;57(2):65-9 - PubMed
- Neurochem Int. 2003 Jan;42(2):173-8 - PubMed
- Int J Biomed Sci. 2008 Jun;4(2):89-96 - PubMed
- Anal Biochem. 1996 Jul 15;239(1):70-6 - PubMed
- J Pharmacol Sci. 2004 Dec;96(4):465-73 - PubMed
- Neurochem Res. 2013 Apr;38(4):780-8 - PubMed
- Eur J Pharmacol. 2011 Oct 1;668(1-2):65-71 - PubMed
- Am J Clin Nutr. 1979 Nov;32(11):2269-71 - PubMed
- J Physiol Biochem. 2001 Mar;57(1):43-56 - PubMed
- Epilepsia. 2009 Jun;50(6):1579-86 - PubMed
- Free Radic Biol Med. 2007 Jul 1;43(1):4-15 - PubMed
- Seizure. 2012 Dec;21(10):780-4 - PubMed
Publication Types